Science Explorer Back to mapMap

Most cited papers from Psyadon Pharmaceuticals (United States)

What are the most cited papers from Psyadon Pharmaceuticals (United States)?

The most cited paper from Psyadon Pharmaceuticals (United States) is "Targeted gene knockout mediated by triple helix forming oligonucleotides" (Alokes Majumdar, Alexander A. Khorlin, Natalia B. Dyatkina et al., 1998), with 149 citations. Next come "Identification of a Novel Mammary-Restricted Cytochrome P450, CYP4Z1, with Overexpression in Breast Carcinoma" (111) and "A D1 Receptor Antagonist, Ecopipam, for Treatment of Tics in Tourette Syndrome" (106).

Showing 45 of 45 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Targeted gene knockout mediated by triple helix forming oligonucleotides Alokes Majumdar, Alexander A. Khorlin, Natalia B. Dyatkina et al. · Nature Genetics Oct 1998 149
2 Identification of a Novel Mammary-Restricted Cytochrome P450, CYP4Z1, with Overexpression in Breast Carcinoma Michael A. Rieger, Reinhard Ebner, David Bell et al. · Cancer Research Apr 2004 111
3 A D1 Receptor Antagonist, Ecopipam, for Treatment of Tics in Tourette Syndrome Donald L. Gilbert, Cathy L. Budman, Harvey S. Singer et al. · Clinical Neuropharmacology 2014 106
4 Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo‐controlled crossover study Donald L. Gilbert, Tanya K. Murphy, Joseph Jankovic et al. · Movement Disorders Aug 2018 85
5 Fluorocyclopentenyl-cytosine with Broad Spectrum and Potent Antitumor Activity Won Jun Choi, Hwa‐Jin Chung, Girish Chandra et al. · Journal of Medicinal Chemistry 23 Apr 2012 71
6 Requirement of hCenexin for Proper Mitotic Functions of Polo-Like Kinase 1 at the Centrosomes Nak‐Kyun Soung, Young Hwi Kang, Keetae Kim et al. · Molecular and Cellular Biology Open access Nov 2006 68
7 Real-World Experience With VMAT2 Inhibitors Nicki Niemann, Joseph J. Jankovic · Clinical Neuropharmacology Mar 2019 51
8 Clavulanic acid: A competitive inhibitor of beta-lactamases with novel anxiolytic-like activity and minimal side effects Deog J. Kim, Jean Anne King, Lisa A. Zuccarelli et al. · Pharmacology Biochemistry and Behavior 25 Apr 2009 47
9 The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2 Dzjemma Sarkisjan, Joris R. Julsing, Kees Smid et al. · PLoS ONE Open access 9 Sep 2016 46
10 Synthesis and anticancer activity of new 1-[(5 or 6-substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives Young Bok Lee, Young‐Dae Gong, Heejeong Yoon et al. · Bioorganic & Medicinal Chemistry 20 Sep 2010 42
11 A Novel Anti‐Cancer Agent, 1‐(3,5‐Dimethoxyphenyl)‐4‐[(6‐Fluoro‐2‐Methoxyquinoxalin‐3‐yl)Aminocarbonyl] Piperazine (RX‐5902), Interferes With β‐Catenin Function Through Y593 Phospho‐p68 RNA Helicase Gina Chun Kost, Mi Yang, Liangwei Li et al. · Journal of Cellular Biochemistry 3 Feb 2015 41
12 Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360) Godefridus J. Peters, Kees Smid, Leonardo Vecchi et al. · Investigational New Drugs 17 Sep 2013 38
13 RX-3117 (fluorocyclopentenyl cytosine): a novel specific antimetabolite for selective cancer treatment Beatrice Balboni, Btissame El Hassouni, Richard J. Honeywell et al. · Expert Opinion on Investigational Drugs Open access 16 Mar 2019 36
14 First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer Anna Capasso, Stacey M. Bagby, Kyrie L. Dailey et al. · Molecular Cancer Therapeutics Open access 5 Sep 2019 34
15 A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease Tanya Khasnavis, Rosa J. Torres, Barbara Sommerfeld et al. · Molecular Genetics and Metabolism 30 Apr 2016 34
16 A Double-blind, Placebo-Controlled Study of the Impact of Galantamine on Anterograde Memory Impairment During Electroconvulsive Therapy John Matthews, Caleb J. Siefert, Mark A. Blais et al. · Journal of Ect 22 Mar 2013 34
17 Clavulanic acid increases dopamine release in neuronal cells through a mechanism involving enhanced vesicle trafficking Gina Chun Kost, Senthil Selvaraj, Young Bok Lee et al. · Neuroscience Letters Open access 22 Sep 2011 34
18 In vivo and in vitro effects of a HIF‐1α inhibitor, RX‐0047 Z. Günnur Dikmen, Ginelle C. Gellert, Pakıze Doğan et al. · Journal of Cellular Biochemistry Open access 14 Feb 2008 34
19 Synthesis, in vitro and in vivo evaluation of 3-arylisoquinolinamines as potent antitumor agents Suhui Yang, Hue Thi My Van, Thanh Nguyen Le et al. · Bioorganic & Medicinal Chemistry Letters 4 Jul 2010 30
20 Lipid–Albumin Nanoparticles (LAN) for Therapeutic Delivery of Antisense Oligonucleotide against HIF-1α Hong Li, Jishan Quan, Mengzi Zhang et al. · Molecular Pharmaceutics 2 Jun 2016 28
21 On-Demand Continuous Manufacturing of Ciprofloxacin in Portable Plug-and-Play Factories: Development of a Highly Efficient Synthesis for Ciprofloxacin Cameron T. Armstrong, Yuma Miyai, Anna Formosa et al. · Organic Process Research & Development 25 Jun 2021 27
22 Clavulanic acid inhibits MPP+-induced ROS generation and subsequent loss of dopaminergic cells Gina Chun Kost, Senthil Selvaraj, Young Bok Lee et al. · Brain Research Open access 30 Jun 2012 26
23 Antitumor activity of a novel antisense oligonucleotide against Akt1 Heejeong Yoon, Deog Joong Kim, Eun Hyun Ahn et al. · Journal of Cellular Biochemistry Open access 19 Aug 2009 26
24 Development of 3-aryl-1-isoquinolinamines as potent antitumor agents based on CoMFA Suhui Yang, Hue Thi My Van, Thanh Nguyen Le et al. · European Journal of Medicinal Chemistry 25 Aug 2010 26
25 Synthesis and evaluation of naphthyridine compounds as antimalarial agents Shuren Zhu, Quan Zhang, Gudise Chandrashekar et al. · Bioorganic & Medicinal Chemistry Letters Open access 17 Sep 2007 25
26 A novel cytidine analog, RX-3117, shows potent efficacy in xenograft models, even in tumors that are resistant to gemcitabine. Mi Young Yang, Young Bok Lee, Chang‐Ho Ahn et al. · PubMed Dec 2014 20
27 Synthesis, anticancer activity and pharmacokinetic analysis of 1-[(substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives Young Bok Lee, Young‐Dae Gong, Deog Joong Kim et al. · Bioorganic & Medicinal Chemistry 27 Dec 2011 20
28 A clinical trial of safety and tolerability for the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease Tanya Khasnavis, Gail Reiner, Barbara Sommerfeld et al. · Molecular Genetics and Metabolism 20 Feb 2016 18
29 Folate receptor-targeted lipid-albumin nanoparticles (F-LAN) for therapeutic delivery of an Akt1 antisense oligonucleotide Hong Li, Yang Liu, Lihua Chen et al. · Journal of drug targeting 29 Jan 2018 17
30 A Single-Blind Study of ‘As-Needed’ Ecopipam for Gambling Disorder Jon Edgar Grant, Brian L. Odlaug, Donald W. Black et al. · Annals of Clinical Psychiatry Aug 2014 17
31 Aliphatic and Alicyclic Diols Induce Melanogenesis in Cultured Cells and Guinea Pig Skin David Alexander Brown, Wu‐Yun Ren, Alexander A. Khorlin et al. · Journal of Investigative Dermatology Open access Apr 1998 17
32 Cognitive Task Performance and Frequency of Alcohol Usage in Young Adults Arit M. Harvanko, Brian L. Odlaug, Liana R. N. Schreiber et al. · Journal of Addiction Medicine 26 Nov 2011 15
33 QSID Tool: a new three-dimensional QSAR environmental tool Dong Sun Park, Jae Min Kim, Young Bok Lee et al. · Journal of Computer-Aided Molecular Design 29 May 2008 15
34 RX-3117 (Fluorocyclopentenyl-Cytosine)-Mediated Down-Regulation of DNA Methyltransferase 1 Leads to Protein Expression of Tumor-Suppressor Genes and Increased Functionality of the Proton-Coupled Folate Carrier Dzjemma Sarkisjan, Joris R. Julsing, Btissame El Hassouni et al. · International Journal of Molecular Sciences Open access 14 Apr 2020 12
35 Bicyclic Monoterpene Diols Induce Differentiation of S91 Melanoma and PC 12 Pheochromocytoma Cells by a Cyclic Guanosine‐Monophosphate‐Dependent Pathway David Alexander Brown, Krystyna B. Lesiak, Wu‐Yun Ren et al. · Pigment Cell Research Feb 1999 10
36 A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma Hani M. Babiker, Peter J. Schlegel, Lee G. Hicks et al. · Investigational New Drugs 21 Aug 2021 6
37 The radiosensitizing effect of fluorocyclopentenyl-cytosine (RX-3117) in ovarian and lung cancer cell lines Dzjemma Sarkisjan, Jaap van den Berg, Evelyn Smit et al. · Nucleosides Nucleotides & Nucleic Acids Open access Dec 2016 5
38 Novel Mycophenolic Adeninebis(Phosphonate)S as Potent Anticancer Agents and Inducers of Cells Differentiation Krzysztof W. Pankiewicz, Krystyna B. Lesiak-Watanabe · Nucleosides and Nucleotides Apr 1999 5
39 Results of a proof-of-concept, dose-finding, double-blind, placebo-controlled study of RX-10100 (Serdaxin®) in subjects with major depressive disorder Robert A. Riesenberg, Joshua Rosenthal, Leslie Moldauer et al. · Psychopharmacology 27 Dec 2011 2
40 Formation and Reactivity of 2,4-Ditriazolyl Pyrimidine C-Nucleoside Derived from Pseudouridine Natalia B. Dyatkina, Alexander A. Khorlin, Kyoichi A. Watanabe · Nucleosides Nucleotides & Nucleic Acids Mar 2000 2
41 4.36 A Randomized, Double-Blind, Placebo-Controlled Study of the D1 Receptor Antagonist Ecopipam for Children and Adolescents With Tourette's Disorder Tanya K. Murphy, Donald L. Gilbert, Cathy L. Budman et al. · Journal of the American Academy of Child & Adolescent Psychiatry Oct 2017 1
42 Synthesis of Methylenebis(Phosphonate) Analogues of Nucleotide Coenzymes. A Novel Coupling Mechanism Krzysztof W. Pankiewicz, Krystyna B. Lesiak, Kyoichi A. Watanabe · Phosphorus, sulfur, and silicon and the related elements 1999 1
43 RX-3117, a Novel Nucleoside Analog Targeting UCK2 Is Active Alone and Synergistic with Ibrutinib and Bendamustine in ABC and DH/DP- Diffuse Large B-Cell Lymphoma Shariful Islam, Umar Nazir Zahid, Laurence S. Cooke et al. · Blood 7 Dec 2017 0
44 International Conference on Nucleic Acid Medical Applications, NAMA Conference Matthews O. Bradley, Rushdi Alul, Purshotam Bhan · Antisense Research and Development 1993 0
45 Interim Analysis of an Open-Label, Multi-Center Study of Ecopipam, a Dopamine D1 Receptor Antagonist, for Tic Reduction in Adults with Tourette Syndrome (P02.058) Donald L. Gilbert, Cathy L. Budman, Harvey S. Singer et al. · Neurology 12 Feb 2013 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.